Instrument Development of Screening Prediabetes Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-10-31

Study Completion Date

2005-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During the past years, many efforts were put on the diagnosis and treatment of DM and its complications. It will be more effective if we can work on the primary prevention for the high risk groups of diabetes and prediabetes such as the early detection. As a first public health step, it is worthwhile to identify prediabetes people in community by screening program. Three thousand persons will be randomly selected from residents of Taichung city. All the participants will fulfill a structured questionnaire and 'Diabetes risk factor screening tool' which American Diabetes Association suggested in 2003. This project will estimate the prevalence of prediabetes in conventional hospital-base population as well as the validity of a screening questionnaire for prediabetes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prediabetic State

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Residents aged 40 and over of Taichung city, Taiwan in October, 2004.

Exclusion Criteria

\-

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lin C Chieh, Professor

Role: PRINCIPAL_INVESTIGATOR

School of Medicine, China Medical University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NSC93-2314-B-039-025

Identifier Type: -

Identifier Source: org_study_id